Offered Price for Lek is More than Fair, Novartis CEO Reiterates
Basel, 12 September - The price that Swiss pharmaceuticals Novartis has offered to pay for the takeover of Slovenian drug-maker Lek is more than fair, the chairman and CEO of Novartis Daniel Vasella told Slovenian journalists who paid a visit to the seat of the Swiss group in Basel on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 2.173 characters (without spaces) or 410 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.